Nexpoint Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,315,094
Closed -$67.9M 165
2022
Q3
$67.9M Buy
+1,315,094
New +$54.4M 4.55% 4

Other funds holding CCXI

Nexpoint Asset Management's CCXI Position: Q4 2022 in Review

Nexpoint Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 1,315,094 shares — an estimated $67.9M sold.

Nexpoint Asset Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $67.9M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Nexpoint Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 1,315,094 ChemoCentryx, Inc. shares in Q4 2022, an estimated $67.9M.
  • Nexpoint Asset Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Nexpoint Asset Management's ChemoCentryx, Inc. position peaked at $67.9M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Nexpoint Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.